Keytruda Clinical Trials
4 recruitingDrug
Phase 24Phase 12
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Biliary CancerBile Duct CancerCancer of the Bile Duct
National Cancer Institute (NCI)60 enrolled1 locationNCT05849480
Recruiting
Phase 2
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.170 enrolled1 locationNCT07122687
Recruiting
Phase 1Phase 2
OH2 Injection in Solid Tumors
MelanomaSolid Tumor
Binhui Biopharmaceutical Co., Ltd.30 enrolled1 locationNCT04386967
Recruiting
Phase 2
Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer
Breast Cancer
Maria Sklodowska-Curie National Research Institute of Oncology78 enrolled1 locationNCT06472583